Literature DB >> 19706775

Behavioral oncology and the war on cancer: partnering with biomedicine.

Michael E Stefanek1, Michael A Andrykowski, Caryn Lerman, Sharon Manne, Karen Glanz.   

Abstract

The call for interdisciplinary research in the war on cancer has escalated over the past several years. Behavioral science has played a key role in cancer control, and several exciting opportunities exist and will develop with the ongoing significant advances made in biomedical science. The current article briefly reviews the maturity of behavioral science in the areas of prevention, early detection, and survivorship and how the partnership of behavioral and biomedical science can effectively impact cancer incidence, morbidity, and mortality.

Entities:  

Mesh:

Year:  2009        PMID: 19706775     DOI: 10.1158/0008-5472.CAN-08-4005

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  1 in total

1.  SERS-based nanobiosensing for ultrasensitive detection of the p53 tumor suppressor.

Authors:  Fabio Domenici; Anna Rita Bizzarri; Salvatore Cannistraro
Journal:  Int J Nanomedicine       Date:  2011-09-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.